The calorie maths tells us that for an average-sized person to lose an inch around the middle, it would require a 4lb ...

Tirzepatide is the active ingredient in an injectable medication (Zepbound) approved by the U.S. Food and Drug Administration ...

‘Game-changing’ oral drug has similar success rate to injections but also comes with potentially serious side-effects ...

Trulicity is a brand-name, injectable dulaglutide medication approved by the U.S. Food and Drug Administration (FDA) to treat ...

Millions of people now take GLP-1 receptor agonist drugs such as semaglutide and tirzepatide for weight loss and diabetes ...

Losing weight might be as simple as sticking to the meals you know, a new study found. People who ate the same meals more often lost more weight during a 12-week weight-loss program, according to a ...

Scientists compared the three leading weight loss drugs and found one clearly outperformed the others, helping people lose the most weight.

New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) and published in The Lancet shows that people who have lost weight using the maximum tolerated ...

For the majority of people who start using GLP-1 medicines with the hope of losing weight, the drugs can feel almost miraculous: Cravings are quieted. Exercise can become easier and more fun. Pounds ...

Data show that orforglipron, a once-daily oral GLP-1 receptor agonist, drives significant, long-term weight reduction in women with obesity or overweight across all 3 stages of menopause: premenopause ...